A Powerful Motivating VISION Compels FleurirABX to Action
The global crisis of bacterial infection and resistance, with its tragic untimely deaths, exorbitant hospitalization costs, and vast health and economic burdens to society, is finally controlled as innovative scientists, healthcare advocates, legislative champions, and insightful investors unite to bring new discoveries, flexible regulatory approaches, supportive legislation and economic incentives and ultimately to deliver safe and effective antibacterials to patients in dire need. These precious new antibacterials are priced to truly reflect their impact on patient health and value to society, and appropriate prescribing and stewardship is achieved.
Our mission is to develop and market effective small-molecule anti-infective drugs that fulfill unmet need, address the global crisis of bacterial resistance, and also bring significant value to partners of and investors in Fleurir ABX, LLC. Keys to success are anti-infective specialization, appropriate scientific and management expertise, and exceptional partnering skills.
Quality, safety, transparency, efficiency and commitment to deliver are paramount in pursuit of our mission.